Nanopharm Ltd, an Aptar Pharma Company

Nanopharm Ltd, an Aptar Pharma Company, specializes in orally inhaled and nasal drug product (OINDP) development and analytics. Founded in 2002 in the United Kingdom, the company aims to tackle industry-wide challenges in converting drugs from concept into viable, effective, and consistent nasal and orally inhaled drug products. As a leading provider of tailored analytical and formulation support in the pharmaceutical industry, Nanopharm leverages unique processing technology and formulation development tools to identify critical material attributes, their relationship with critical processing parameters, and drug product functionality. With a focus on all phases of drug development for orally inhaled drug products, the company plays a crucial role in advancing the pharmaceutical industry's capabilities in this niche.